Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail
-

Briefing Information for the August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee

Vision impaired people having problems accessing certain pages of a PDF file             

may call (301) 796-3634 for assistance

 

FDA

Disclaimer

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. ยง 552).

FDA Briefing Version 1 (pdf)

FDA Briefing Version 2 (pdf)

Errata (pdf)

***************

 

Amgen, Inc.

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

 

Briefing Material (pdf)

-
-